STOCK TITAN

PTC Therapeutics to Participate at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) will present an overview at upcoming investor conferences: Wells Fargo's 17th Annual Healthcare Conference on Sept. 8 at 1:55 p.m. EDT and Morgan Stanley's 20th Annual Global Healthcare Conference on Sept. 12 at 4:15 p.m. EDT. These presentations will be available via live webcast on PTC's Investor page and archived for 30 days. PTC focuses on developing treatments for rare disorders, enhancing access to innovative medicines for patients with unmet medical needs.

Positive
  • None.
Negative
  • None.

SOUTH PLAINFIELD, N.J., Sept. 1, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences:

Wells Fargo 17th Annual Healthcare Conference
Thursday, Sept. 8, at 1:55 p.m. EDT

Morgan Stanley 20th Annual Global Healthcare Conference
Monday, Sept. 12, at 4:15 p.m. EDT

The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. 

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-301616156.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics present at the Wells Fargo Healthcare Conference?

PTC Therapeutics will present at the Wells Fargo 17th Annual Healthcare Conference on September 8, 2022, at 1:55 p.m. EDT.

What date is PTC presenting at the Morgan Stanley Healthcare Conference?

PTC will present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 4:15 p.m. EDT.

Where can I watch PTC Therapeutics' conference presentations?

The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC's website.

How long will the PTC conference presentations be archived?

The presentations will be archived for 30 days following the live event.

What is PTC Therapeutics' focus?

PTC Therapeutics is dedicated to discovering and developing medicines for patients with rare disorders.

PTC Therapeutics, Inc.

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Stock Data

3.39B
77.13M
2.34%
105.79%
6.06%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WARREN